Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Cross-species comparison of orthologous gene expression in human bladder cancer and carcinogen-induced rodent models.

Lu Y, Liu P, Wen W, Grubbs CJ, Townsend RR, Malone JP, Lubet RA, You M.

Am J Transl Res. 2010 Sep 20;3(1):8-27.

2.

Molecular credentialing of rodent bladder carcinogenesis models.

Williams PD, Lee JK, Theodorescu D.

Neoplasia. 2008 Aug;10(8):838-46.

3.

Cross-species comparison of biological themes and underlying genes on a global gene expression scale in a mouse model of colorectal liver metastasis and in clinical specimens.

Bandapalli OR, Kahlert C, Hellstern V, Galindo L, Schirmacher P, Weitz J, Brand K.

BMC Genomics. 2008 Sep 29;9:448. doi: 10.1186/1471-2164-9-448.

4.

MYLK and MYL9 expression in non-small cell lung cancer identified by bioinformatics analysis of public expression data.

Tan X, Chen M.

Tumour Biol. 2014 Dec;35(12):12189-200. doi: 10.1007/s13277-014-2527-3. Epub 2014 Sep 2.

PMID:
25179839
5.

Screening candidate genes associated with bladder cancer using DNA microarray.

Xu A, Wang C, Sun S.

Mol Med Rep. 2014 Dec;10(6):3087-91. doi: 10.3892/mmr.2014.2667. Epub 2014 Oct 15.

PMID:
25323786
6.

Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.

Haram KM, Peltier HJ, Lu B, Bhasin M, Otu HH, Choy B, Regan M, Libermann TA, Latham GJ, Sanda MG, Arredouani MS.

Prostate. 2008 Oct 1;68(14):1517-30. doi: 10.1002/pros.20803.

PMID:
18668517
7.

Identification of gene expression signature modulated by nicotinamide in a mouse bladder cancer model.

Kim SK, Yun SJ, Kim J, Lee OJ, Bae SC, Kim WJ.

PLoS One. 2011;6(10):e26131. doi: 10.1371/journal.pone.0026131. Epub 2011 Oct 10.

8.

Bioinformatics approaches for cross-species liver cancer analysis based on microarray gene expression profiling.

Fang H, Tong W, Perkins R, Shi L, Hong H, Cao X, Xie Q, Yim SH, Ward JM, Pitot HC, Dragan YP.

BMC Bioinformatics. 2005 Jul 15;6 Suppl 2:S6.

9.

Complexity, retinoid-responsive gene networks, and bladder carcinogenesis.

Hurst RE, Waliszewski P, Waliszewska M, Bonner RB, Benbrook DM, Dar A, Hemstreet GP 3rd.

Adv Exp Med Biol. 1999;462:449-67. Review.

PMID:
10599447
10.

DNA microarray expression profiling of bladder cancer allows identification of noninvasive diagnostic markers.

Mengual L, Burset M, Ars E, Lozano JJ, Villavicencio H, Ribal MJ, Alcaraz A.

J Urol. 2009 Aug;182(2):741-8. doi: 10.1016/j.juro.2009.03.084. Epub 2009 Jun 18.

PMID:
19539325
11.

Common and differentially expressed long noncoding RNAs for the characterization of high and low grade bladder cancer.

Wang M, Xiao X, Zeng F, Xie F, Fan Y, Huang C, Jiang G, Wang L.

Gene. 2016 Oct 30;592(1):78-85. doi: 10.1016/j.gene.2016.07.042. Epub 2016 Jul 20.

PMID:
27451077
12.

Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors.

Wei M, Wanibuchi H, Morimura K, Iwai S, Yoshida K, Endo G, Nakae D, Fukushima S.

Carcinogenesis. 2002 Aug;23(8):1387-97.

PMID:
12151359
13.

[Influence of hepatocyte cell adhesion molecule on gene expression profile of human bladder transitional cell carcinoma cell line].

Wang QJ, Lv CK, Tao J, Du HF, Fan YR, Song XD, Luo CL.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013 Apr;35(2):190-8. doi: 10.3881/j.issn.1000-503X.2013.02.012. Chinese.

14.

Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.

Luo HB, Li B, Yuan WG, Xu CR.

J Huazhong Univ Sci Technolog Med Sci. 2015 Oct;35(5):730-5. doi: 10.1007/s11596-015-1498-y. Epub 2015 Oct 22.

PMID:
26489630
15.

Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model.

Stearman RS, Dwyer-Nield L, Zerbe L, Blaine SA, Chan Z, Bunn PA Jr, Johnson GL, Hirsch FR, Merrick DT, Franklin WA, Baron AE, Keith RL, Nemenoff RA, Malkinson AM, Geraci MW.

Am J Pathol. 2005 Dec;167(6):1763-75.

16.
17.

Analysis of the interaction of extracellular matrix and phenotype of bladder cancer cells.

Dozmorov MG, Kyker KD, Saban R, Knowlton N, Dozmorov I, Centola MB, Hurst RE.

BMC Cancer. 2006 Jan 13;6:12.

18.

Deregulation of Rab and Rab effector genes in bladder cancer.

Ho JR, Chapeaublanc E, Kirkwood L, Nicolle R, Benhamou S, Lebret T, Allory Y, Southgate J, Radvanyi F, Goud B.

PLoS One. 2012;7(6):e39469. doi: 10.1371/journal.pone.0039469. Epub 2012 Jun 19.

19.

Altered gene expression profile in mouse bladder cancers induced by hydroxybutyl(butyl)nitrosamine.

Yao R, Lemon WJ, Wang Y, Grubbs CJ, Lubet RA, You M.

Neoplasia. 2004 Sep-Oct;6(5):569-77.

20.

miRNA-100 inhibits human bladder urothelial carcinogenesis by directly targeting mTOR.

Xu C, Zeng Q, Xu W, Jiao L, Chen Y, Zhang Z, Wu C, Jin T, Pan A, Wei R, Yang B, Sun Y.

Mol Cancer Ther. 2013 Feb;12(2):207-19. doi: 10.1158/1535-7163.MCT-12-0273. Epub 2012 Dec 27.

Supplemental Content

Support Center